These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 26823210

  • 1. The efficacy of fluticasone furoate administered in the morning or evening is comparable in patients with persistent asthma.
    Kempsford RD, Bal J, Baines A, Renaux J, Ravindranath R, Thomas PS.
    Respir Med; 2016 Mar; 112():18-24. PubMed ID: 26823210
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
    Medley H, Orozco S, Allen A.
    Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
    [Abstract] [Full Text] [Related]

  • 3. The efficacy of once-daily fluticasone furoate/vilanterol in asthma is comparable with morning or evening dosing.
    Kempsford RD, Oliver A, Bal J, Tombs L, Quinn D.
    Respir Med; 2013 Dec; 107(12):1873-80. PubMed ID: 24200619
    [Abstract] [Full Text] [Related]

  • 4. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
    Boscia JA, Pudi KK, Zvarich MT, Sanford L, Siederer SK, Crim C.
    Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
    [Abstract] [Full Text] [Related]

  • 5. Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trial.
    Busse WW, Bleecker ER, Bateman ED, Lötvall J, Forth R, Davis AM, Jacques L, Haumann B, Woodcock A.
    Thorax; 2012 Jan; 67(1):35-41. PubMed ID: 21828231
    [Abstract] [Full Text] [Related]

  • 6. Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroids.
    Bleecker ER, Bateman ED, Busse WW, Woodcock A, Frith L, House KW, Jacques L, Davis AM, Haumann B, Lötvall J.
    Ann Allergy Asthma Immunol; 2012 Nov; 109(5):353-358.e4. PubMed ID: 23062392
    [Abstract] [Full Text] [Related]

  • 7. Dose effect of once-daily fluticasone furoate in persistent asthma: a randomized trial.
    Bateman ED, Bleecker ER, Lötvall J, Woodcock A, Forth R, Medley H, Davis AM, Jacques L, Haumann B, Busse WW.
    Respir Med; 2012 May; 106(5):642-50. PubMed ID: 22342538
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: a 24-week placebo and active-controlled randomised trial.
    Lötvall J, Bleecker ER, Busse WW, O'Byrne PM, Woodcock A, Kerwin EM, Stone S, Forth R, Jacques L, Bateman ED.
    Respir Med; 2014 Jan; 108(1):41-9. PubMed ID: 24295556
    [Abstract] [Full Text] [Related]

  • 9. Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma.
    Woodcock A, Bleecker ER, Busse WW, Lötvall J, Snowise NG, Frith L, Jacques L, Haumann B, Bateman ED.
    Respir Res; 2011 Dec 21; 12(1):160. PubMed ID: 22188590
    [Abstract] [Full Text] [Related]

  • 10. The effect of fluticasone furoate/umeclidinium in adult patients with asthma: a randomized, dose-ranging study.
    Lee LA, Yang S, Kerwin E, Trivedi R, Edwards LD, Pascoe S.
    Respir Med; 2015 Jan 21; 109(1):54-62. PubMed ID: 25452139
    [Abstract] [Full Text] [Related]

  • 11. Once-daily tiotropium Respimat(®) 5 μg is an efficacious 24-h bronchodilator in adults with symptomatic asthma.
    Timmer W, Moroni-Zentgraf P, Cornelissen P, Unseld A, Pizzichini E, Buhl R.
    Respir Med; 2015 Mar 21; 109(3):329-38. PubMed ID: 25661281
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of fluticasone furoate 100 μg and 200 μg once daily in the treatment of moderate-severe asthma in adults and adolescents: a 24-week randomised study.
    Woodcock A, Lötvall J, Busse WW, Bateman ED, Stone S, Ellsworth A, Jacques L.
    BMC Pulm Med; 2014 Jul 09; 14():113. PubMed ID: 25007865
    [Abstract] [Full Text] [Related]

  • 13. Randomised, double-blind, placebo-controlled, cross-over single dose study of the bronchodilator duration of action of combination fluticasone furoate/vilanterol inhaler in adult asthma.
    Braithwaite I, Williams M, Power S, Pilcher J, Weatherall M, Baines A, Moynihan J, Kempsford R, Beasley R, FF/VI Study Team.
    Respir Med; 2016 Oct 09; 119():115-121. PubMed ID: 27692131
    [Abstract] [Full Text] [Related]

  • 14. Fluticasone furoate/vilanterol 200/25 mcg in Asian asthma patients: a randomized trial.
    Lin J, Kang J, Lee SH, Wang C, Zhou X, Crawford J, Jacques L, Stone S.
    Respir Med; 2015 Jan 09; 109(1):44-53. PubMed ID: 25524507
    [Abstract] [Full Text] [Related]

  • 15. Fluticasone furoate (FF)/vilanterol (100/25 mcg or 200/25 mcg) or FF (100 mcg) in persistent asthma.
    Bernstein DI, Bateman ED, Woodcock A, Toler WT, Forth R, Jacques L, Nunn C, O'Byrne PM.
    J Asthma; 2015 Jan 09; 52(10):1073-83. PubMed ID: 26291137
    [Abstract] [Full Text] [Related]

  • 16. Fluticasone furoate-vilanterol 100-25 mcg compared with fluticasone furoate 100 mcg in asthma: a randomized trial.
    Bleecker ER, Lötvall J, O'Byrne PM, Woodcock A, Busse WW, Kerwin EM, Forth R, Medley HV, Nunn C, Jacques L, Bateman ED.
    J Allergy Clin Immunol Pract; 2014 Jan 09; 2(5):553-61. PubMed ID: 25213048
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of once-daily fluticasone furoate 50 mcg in adults with persistent asthma: a 12-week randomized trial.
    O'Byrne PM, Woodcock A, Bleecker ER, Bateman ED, Lötvall J, Forth R, Medley H, Jacques L, Busse WW.
    Respir Res; 2014 Aug 11; 15(1):88. PubMed ID: 25108545
    [Abstract] [Full Text] [Related]

  • 18. Tolerability of fluticasone furoate/vilanterol combination therapy in children aged 5 to 11 years with persistent asthma.
    Oliver A, VanBuren S, Allen A, Hamilton M, Tombs L, Inamdar A, Kempsford R.
    Clin Ther; 2014 Jun 01; 36(6):928-939.e1. PubMed ID: 24793536
    [Abstract] [Full Text] [Related]

  • 19. Fluticasone furoate/vilanterol (100/25; 200/25 μg) improves lung function in COPD: a randomised trial.
    Martinez FJ, Boscia J, Feldman G, Scott-Wilson C, Kilbride S, Fabbri L, Crim C, Calverley PM.
    Respir Med; 2013 Apr 01; 107(4):550-9. PubMed ID: 23332861
    [Abstract] [Full Text] [Related]

  • 20. Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial.
    Woodcock A, Bateman ED, Busse WW, Lötvall J, Snowise NG, Forth R, Jacques L, Haumann B, Bleecker ER.
    Respir Res; 2011 Oct 06; 12(1):132. PubMed ID: 21977941
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.